The Vitality Blog

Two Simple Strength Tests Predicted Which Older Women Lived Longer. Here's What That Means in Midlife.

A 2026 JAMA Network Open study of 5,472 older women found grip strength and chair-stand speed each predicted lower mortality. Here's what it means before you're 63.

Night Sweats Wrecking Your Sleep? A 2026 Trial Tested Four Sessions of Therapy Instead of a Pill

A 2026 randomized pilot trial found 69% of women with night sweats and insomnia reached "no clinically significant insomnia" after four therapy sessions. Here's what held up and what didn't.

A 2025 Trial Found Generic Weight-Loss Advice Failed in Perimenopause. Here's What Actually Worked.

A 2025 RCT of 160 perimenopausal women found individualized programs beat generic advice 3-to-1 on meaningful weight loss. Here's what was actually different.

The Surprising Cognitive Case for Slowing Down Your Cardio

A 2026 RCT found postmenopausal women got a bigger cognitive boost from aerobic exercise than premenopausal women did. Here's the mechanism behind it.

How to Read Your Own Bloodwork Without Panicking

A 2025 study found nearly 1 in 4 patients don't know how to interpret their own lab results. Here's a calm framework for reading yours before you panic.

The 10-Minute Habit That Predicts Whether Your Resolution Survives February

A 2025 analysis of gym data found half of new members quit by week 6. The ones who didn't shared one specific early pattern. Here's what it was.

Fatigue Triage: Iron, Thyroid, or Sleep — How to Tell the Difference Before You Guess

A 2026 study found 67% of women tested for fatigue had low ferritin, yet most never got the test. Here's how to actually narrow down what's behind yours.

Zone 2 vs. HIIT for Fat Loss: What the Research Actually Shows

Two 2024-2025 studies pit HIIT against steady-state cardio for fat loss head to head. Here's what the numbers actually show, and what they don't.

Anti-Inflammatory Diet Claims We Can (and Can't) Back With Evidence

A 2026 umbrella review of 30 systematic reviews and a network meta-analysis of 60 RCTs show which anti-inflammatory diet claims hold up, and which don't.

How to Find Your Zone 2 Without a Lab Test

A 2026 study of 1,411 runners shows fixed heart-rate formulas miss your real zone 2 by a lot. Here's what actually works instead, no lab required.

Does Zone 2 Training Help With Menopausal Weight Redistribution?

Zone 2 lowers waist circumference in postmenopausal women, but a 2026 meta-analysis and a landmark RCT show visceral fat doesn't respond to volume the way you'd expect.

The Menopause Weight Redistribution Nobody Warns You About

Menopause doesn't just add weight, it moves it. A Dartmouth, MA clinic on the SWAN data showing why visceral fat surges and your tape measure misses it.

Can You Out-Exercise Inflammation? What the Research Actually Shows

Exercise lowers inflammation, but not all types equally. A Dartmouth, MA clinic breaks down a 2026 meta-analysis on which workouts actually move CRP.

The Early Signs of Perimenopause Most Women (and Some Doctors) Miss

Perimenopause can start 7+ years before your last period. A Dartmouth, MA clinic on the early signs that get dismissed as stress or aging.

Menopause Hormone Therapy: A Plain-English Guide to the Options

Estrogen alone or combined? Pill, patch, or vaginal? A Dartmouth, MA clinic breaks down the actual menopause hormone therapy options in plain English.

Perimenopause Isn't One Thing, and That's Why Your Symptoms Don't Match Your Friend's

A global 2026 study of 12,681+ women shows how differently perimenopause presents. A Dartmouth, MA clinic on why hormonal chaos, not decline, explains it.

Reading CRP and ESR: What Inflammation Bloodwork Can and Can't Tell You

CRP and ESR both flag inflammation, but they measure different things and can disagree. A Dartmouth, MA clinic on how to actually read these labs.

What Is Zone 2 Training, and Does the Research Actually Back the Hype?

Zone 2 cardio is everywhere. A Dartmouth, MA clinic breaks down what zone 2 training actually is, and what a 2025 review found when it checked the evidence.

5 Questions to Ask Before You Start a Weight Loss Medication

Before you start a GLP-1 class weight loss medication, ask these 5 questions. An RN-led Dartmouth, MA clinic on what real medical supervision looks like.

Why Does Heart Risk Change During Menopause, and What Should You Actually Measure?

Heart risk climbs during the menopause transition, not after it. Which labs actually matter — ApoB, Lp(a), fasting insulin — and how RN-led care tracks them.

What Happens When You Stop Weight Loss Medication?

What the SURMOUNT-4 and STEP 1 data show about weight regain after stopping weight loss medication, and how RN-led, provider-prescribed care plans the off-ramp.

The Fastest Bone Loss of Your Life Happens Before Your Last Period — Not After It

Bone loss speeds up about a year before your last period. What the SWAN study found, when a DXA is advised, and how RN-led lab review works.

GLP-1s and Alcohol: Why People on Weight Loss Medication Are Drinking Less

People on GLP-1 class medication report drinking less. Here's what two randomized trials actually found, and what it means for medically supervised weight loss.

Why Does Sleep Apnea Show Up After Menopause — and Why Does It Get Missed in Women?

Sleep apnea often surfaces after menopause and gets missed in women. What the research shows, how symptoms differ, and how RN-led care in Dartmouth, MA fits in.

Is Cardio a Waste of Time in Perimenopause? What VO2 Max Actually Measures

Cardio won't fix midlife weight gain, but VO2 max is a real, trainable health marker. What the research shows and what to measure instead of the scale.

Why Does Brain Fog Happen in Perimenopause?

Brain fog in perimenopause is real and measurable. See what research shows and how RN-led, provider-supervised testing in Dartmouth can help.

Why Does Weight Loss Stall in Perimenopause When Sleep Falls Apart?

Short sleep changes what a calorie deficit does: less fat lost, more muscle given up. What an RN-led clinic in Dartmouth, MA measures first.

Losing Weight on a GLP-1? Here's How Much of It Is Muscle

Roughly 39% of GLP-1 weight loss can be lean mass. What protein, strength training, and medical supervision change about that ratio.

How to Protect Muscle on GLP-1 Weight Loss Medication

Weight loss medication can cost muscle as well as fat. An RN-led look at the research on protein, strength training, and monitoring in Dartmouth, MA.

Menopause Is a Metabolic Event, Not Just Something to Endure

Menopause isn't just symptoms to manage. Real, measurable changes happen to muscle and fat. Here's what The Menopause Society's own data shows. MA.

Low Ferritin in Women: Why "Normal" Bloodwork Can Still Miss Low Iron

Normal hemoglobin can hide low iron stores. Learn what ferritin measures, why women in perimenopause run low, and how RN-led lab testing in Dartmouth helps.

How Do You Protect Muscle on Medically Supervised Weight Loss Medication?

Losing weight on GLP-1 medication? How protein and strength training help protect muscle, with RN-led supervision and lab work in Dartmouth, MA.

Medically Supervised Weight Loss in Dartmouth, MA: What "Medically Supervised" Should Actually Mean

What separates medically supervised weight loss from a telehealth script: real monitoring, a real threshold, and someone who adjusts the plan. MA.

Ferritin, Fatigue, and the Number a Standard CBC Never Shows You

Tired but still told your labs are normal? See what ferritin measures, why a CBC can miss low iron, and how RN-led lab testing works in Dartmouth, MA.

The Minimum Effective Dose of Strength Training After 40

Research shows real strength and muscle gains from less training than most people assume is required after 40. Here's the actual data. MA.

Vitamin D Testing: What the Screening Guidelines Actually Say (And What They Don't)

The USPSTF says there's not enough evidence to screen every adult for vitamin D. Here's what that actually means, and who testing still helps. MA.

FDA Drops the HRT Black Box Warning: What Actually Changed for Menopause Hormone Therapy

In Feb. 2026 the FDA removed the black box warning from 6 menopause hormone therapy products. Here's what changed, and what still matters. MA.

TSH Alone Can Miss a Thyroid Problem: What Free T4, Free T3, and Antibodies Actually Add

A normal TSH doesn't always mean your thyroid is fine. Here's what free T4, free T3, and antibody testing add that a standard panel often skips. MA.

Protein and Lifting Volume: The Two Interventions With the Strongest Data for Midlife Women

Two interventions have the strongest data for midlife body composition: protein above 1.2 g/kg and higher-volume strength training. Here are the numbers.

Inflammation and Midsection Weight Gain: Which One Causes the Other?

The wellness world says inflammation drives midsection weight gain. The research points the other direction. What hs-CRP shows and what it doesn’t.

Why the Scale Misses What's Happening in Perimenopause

In perimenopause, weight can hold steady while fat rises and muscle falls. Here’s what the SWAN data shows and what to measure instead of the scale.

Lp(a) and ApoB: What the New 2026 Cholesterol Guidelines Actually Changed

New 2026 heart guidelines recommend testing almost nobody's had. Here's what Lp(a) and ApoB actually show that standard cholesterol misses. Dartmouth, MA.

Compounded Semaglutide and Tirzepatide: What the FDA's 2026 Rules Actually Mean

The FDA is closing the door on compounded GLP-1s in 2026. Here's what changed, what's still legal, and what it means if you're using one. Dartmouth, MA.

The FDA Just Loosened Testosterone Labeling. Here's What That Does and Doesn't Mean for You.

The FDA loosened testosterone labeling in 2026. Here is what changed, what did not, and how proper lab testing works at our RN-led Dartmouth, MA clinic.

GLP-1 Pills vs. Injections: What the Oral Weight Loss Medications Actually Deliver

GLP-1 medications now come in pill form, and two are FDA-approved for weight management in adults with obesity or overweight. In the OASIS 4 trial, oral semaglutide 25 mg produced an average 13.6% body weight reduction over 64 weeks, versus 2.2% on placebo.

Zinc for Colds and Immunity: What Actually Works

Zinc gets marketed hard for immune support. Here's what a 2024 Cochrane review found, and a real risk high-dose users should know about. Dartmouth, MA.

Magnesium and Sleep: What the Research Shows

Magnesium is everywhere in sleep marketing. Here's what the actual trials found, and why a normal blood test can still miss a real deficiency. Dartmouth, MA.

B12 and MTHFR Testing: What Actually Matters

Everyone's talking about MTHFR testing. Here's what actually predicts B12 problems, and why the genetic test usually doesn't. Dartmouth, MA.

Creatine for Women: What the Research Shows

Creatine isn't just for lifters. Here's what a 2026 meta-analysis of postmenopausal women actually found about strength and safety. Dartmouth, MA.

Cortisol and Sleep Testing: What Actually Works

Cortisol testing is trending for stress and sleep. Here's what actually measures it well, and why "adrenal fatigue" isn't real. Dartmouth, MA.

CGMs for Non-Diabetics: What the Data Shows

Continuous glucose monitors are trending for people without diabetes. Here's what the actual research shows, and what it doesn't. Dartmouth, MA.

Losing Muscle on a GLP-1? Here's the Fix

GLP-1 weight loss isn't all fat. Here's what the research says about muscle loss, and how resistance training changes the outcome. Dartmouth, MA.

"Normal" Labs vs. Optimal Ranges: What's the Difference?

Your labs can say normal and still miss the mark. How TSH, vitamin D, ferritin, and testosterone ranges actually work. RN-led testing in Dartmouth, MA.

Perimenopause vs. Menopause: What's the Difference?

Perimenopause and menopause aren't the same stage. Learn the real clinical difference and why it changes your care plan in Dartmouth, MA.

Your Labs Say "Normal" — So Why Do You Still Feel Insulin Resistant?

Your labs can say "normal" and you can still be insulin resistant. How HOMA-IR and fasting insulin actually work, with RN-led testing in Dartmouth, MA.

Semaglutide vs. Tirzepatide vs. Retatrutide: What the Trial Data Actually Shows

Comparing the three GLP-1 medications by the actual trial data: what's FDA-approved, what's investigational, and how we choose at Vitality Dartmouth.

BPC-157's Regulatory Status Is Changing: What the FDA's July 2026 Vote Actually Means

The FDA's July 2026 committee recommended BPC-157 for legal compounding again. What it means, what's still unproven, and RN-led sourcing — Dartmouth, MA.

Does Adding Hormone Therapy to GLP-1s Boost Menopause Weight Loss? What a New Mayo Clinic Study Found

A new Mayo Clinic study found women combining hormone therapy with tirzepatide lost 35% more weight. What it means, and doesn't, from an RN in Dartmouth, MA.

Retatrutide's Phase 3 Results Are In: What They Mean for Medically Supervised Weight Loss

Retatrutide's Phase 3 TRIUMPH-1 trial showed up to 28% weight loss. An RN explains what the results mean and how supervised programs work in Dartmouth, MA.

What Can Genomic and Lab Testing Actually Tell You About Your Health?

An RN explains what DNA and lab biomarker testing can and can't tell you, and how the two work together in a real, measurable health plan.

GLP-1 Microdosing and Menopause: What the Trend Gets Right (and Wrong)

An RN-supervised look at GLP-1 microdosing for menopause weight gain: what the evidence shows, the real risks, and who it may fit.

Retatrutide: The Next Generation of Metabolic and Weight Loss Science

How retatrutide’s triple-receptor action targets GLP-1, GIP, and glucagon pathways to support fat loss and metabolic health.

GHK-Cu: The Copper Peptide Behind Skin, Hair, and Tissue Repair

How the copper-binding peptide GHK-Cu supports collagen production, wound healing, hair follicles, and skin quality.

Epitalon and Cellular Aging: Telomeres, Sleep, and the Longevity Conversation

What the research actually says about epitalon, telomerase activity, melatonin rhythm, and where it fits in a longevity framework.

Tesamorelin and Visceral Fat: The Deep Belly Fat Nobody Talks About

Why visceral fat drives cardiometabolic risk, and how tesamorelin’s growth-hormone-releasing action targets it specifically.

21 Day Burn Challenge

Understanding Peptide Therapy: A Comprehensive Guide

Discover how peptide therapy works and why it's becoming a cornerstone of modern wellness optimization.

Vitality Dartmouth's 3 Pillars of Health and Wellness

Discover how Diet, Exercise, and Recovery form the foundation of optimal health and how our integrated approach can help you achieve lasting vitality.

The Science Behind GLP-1 Agonists for Weight Loss

Learn about the mechanisms that make semaglutide and other GLP-1 agonists effective for sustainable weight management.

BPC-157: The Healing Peptide Athletes Are Talking About

Explore how BPC-157 supports tissue repair and recovery for athletes and active individuals.

Hormone Optimization During Perimenopause

Understanding the hormonal changes during perimenopause and how targeted therapies can restore balance.

NAD+ and Cellular Longevity: What the Research Shows

Dive into the science of NAD+ supplementation and its role in promoting healthy aging.

Your First Consultation: What to Expect

A step-by-step guide to your initial visit at Vitality Dartmouth and how we create your personalized protocol.